Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 208 Records) |
Query Trace: Adenocarcinoma and MET[original query] |
---|
Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study. Targeted oncology 2022 9 17 (6): 675-682. Akli Assya, Girard Nicolas, Fallet Vincent, Rousseau-Bussac Gaelle, Gounant Valérie, Friard Sylvie, Trédaniel Jean, Dujon Cécile, Wislez Marie, Duchemann Boris, Giroux-Leprieur Etien |
Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations. Cancers 2022 08 14 (16): . Zhao Rongjie, Li Hongshen, Ge Weiting, Zhu Xiuming, Zhu Liang, Wan Xiangbo, Wang Guanglan, Pan Hongming, Lu Jie, Han Weido |
A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma. Frontiers in oncology 2022 12 897323. Dong Yi, Li Yingge, Yao Yi, Song Qib |
Analysis of actionable genetic alterations in lung carcinoma from the VA National Precision Oncology Program. Seminars in oncology 2022 Jul . Jalal Shadia I, Guo Aixia, Ahmed Sara, Kelley Michael |
A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib. BMC medical genomics 2022 Jun 15 (1): 141. Chen Yan, Jiang Bo, He Yuange, Zhang Chu, Zhou Wenjie, Fang Cheng, Gu Dejian, Zhang Minxia, Ji Mei, Shi Juntao, Yang X |
Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC cancer 2022 May 22 (1): 580. Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic |
The diagnostic importance of pathogenic variants and variant coexistence determined by NGS-based liquid biopsy approach in patients with lung adenocarcinoma. Molecular and cellular probes 2022 5 64 101819. Cine Naci, Ali Sen Emin, Demir Gulhan, Gokbayrak Merve, Guzdolu Eda, Sertdemir Nilufer, Aydin Duygu, Kurtas Omer, Reka Seda, Sunnetci-Akkoyunlu Deniz, Eren-Keskin Seda, Uygun Kazim, Cabuk Devrim, Gorkem Aksu Maksut, Zafer Canturk Nuh, Savli Hak |
Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma. Journal of Cancer 2022 4 13 (5): 1565-1572. Wu Xiaonan, Zhao Jun, Yang Ling, Nie Xin, Wang Zheng, Zhang Ping, Li Chao, Hu Xueqing, Tang Min, Yi Yuting, Du Xinhua, Xia Xuefeng, Guan Yanfang, Yu Zicheng, Gu Wenguang, Quan Xiangming, Li Lin, Shi Ho |
Case Report: A Lung Adenocarcinoma With Brain Metastasis Harbored Novel MET 14 Skipping Alteration Sensitive to Savolitinib. Frontiers in oncology 2022 4 12 863560. Li Jian, Feng Yun, Tan Yuan, Duan Qianqian, Zhang Q |
[Clinical Characteristics and Prognosis of 76 Lung Adenocarcinoma Patients ?Harboring EGFR Mutations with Pleural Effusion at Initial Diagnosis: ?A Single-center Retrospective Study]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2022 3 25 (3): 156-166. Yin Wencheng, Zhang Hua, Gu Yangchun, Yi Fumei, Li Qian, Liu Yan'e, Yao Yanhong, Liu Zhentao, Cao Baosh |
Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma. The oncologist 2022 3 27 (6): 476-486. Mack Philip C, Klein Michael I, Ayers Kristin L, Zhou Xiang, Guin Sunny, Fink Marc, Rossi Michael, Ai-Kateb Hussam, O'Connell Timmy, Hantash Feras M, Oh William K, Newman Scott, Schadt Eric E, Chen Rong, Hirsch Fred |
Clinical and CT patterns to predict EGFR mutation in patients with non-small cell lung cancer: A systematic literature review and meta-analysis. European journal of radiology open 2022 2 9 100400. Ortiz Andrés Felipe Herrera, Camacho Tatiana Cadavid, Vásquez Andrés Francisco, Del Castillo Herazo Valeria, Neira Juan Guillermo Arámbula, Yepes María Mónica, Camacho Eduard Cadav |
Clinicopathological and genetic analyses of pulmonary enteric adenocarcinoma. Journal of clinical pathology 2022 12 . Okada Fumi, Takeda Maiko, Fujii Tomomi, Uchiyama Tomoko, Sasaki Shoh, Matsuoka Minami, Nitta Yuji, Terada Chiyoko, Maebo Katsuya, Morita Kohei, Ishida Eiwa, Sawabata Noriyoshi, Ohbayashi Chi |
The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk. BMC urology 2022 11 22 (1): 196. Yang Yong, Zhang Guoying, Hu Chen, Luo Wei, Jiang Haiyang, Liu Shaoyou, Yang Ho |
Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction. Frontiers in oncology 2022 11 12 941868. Lao Yueqiong, Wang Yuqian, Yang Jie, Liu Tianyuan, Ma Yuling, Luo Yingying, Sun Yanxia, Li Kai, Zhao Xuan, Niu Xiangjie, Xi Yiyi, Zhong |
Dramatic response to neoadjuvant savolitinib in marginally resectable lung adenocarcinoma with MET exon 14 skipping mutation: A case report and literature review. Frontiers in oncology 2022 11 12 1006634. Tian Jiangfang, Lin Zhen, Chen Yueyun, Fu Yang, Ding Zhen |
Dynamic changes in the systemic immune-inflammation index predict the prognosis of EGFR-mutant lung adenocarcinoma patients receiving brain metastasis radiotherapy. BMC pulmonary medicine 2022 Mar 22 (1): 75. Wang Qi, Tan Xiaojing, Deng Guangchuan, Fu Shuai, Li Jianbin, Li Zhenxia |
MET overexpression in EGFR L858R mutant treatment-naïve advanced lung adenocarcinoma correlated with poor prognosis: a real-world retrospective study. Journal of cancer research and clinical oncology 2022 Jul . Wang Na, Zhu Yili, Wu Ying, Huang Bo, Wu Junhua, Zhang Ruiguang, Fan Jun, Nie X |
Patterns of spread and genetic alterations of primary endometrioid carcinomas of the ovary. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023 8 . Varvara Mazina, Kyle Devins, Lauren Philp, Alexandra S Bercow, Kaitlyn James, Amy Bregar, Rachel Clark Sisodia, Esther Oliva, Marcela Del Carm |
Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study. Targeted oncology 2023 6 . Hélène Babey, Philippe Jamme, Hubert Curcio, Jean Baptiste Assié, Remi Veillon, Hélène Doubre, Maurice Pérol, Florian Guisier, Eric Huchot, Chantal Decroisette, Lionel Falchero, Romain Corre, Alexis Cortot, Christos Chouaïd, Renaud Descou |
Durable Response to Chemoimmunotherapy of a Lung Adenocarcinoma Harboring a MET Exon 14 Skipping Mutation. Cureus 2023 4 15 (2): e35545. Nitta Naohiro, Morimoto Yoshie, Tani Nozomi, Shimamoto Takayu |
The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature 2023 4 616 (7957): 525-533. Frankell Alexander M, Dietzen Michelle, Al Bakir Maise, Lim Emilia L, Karasaki Takahiro, Ward Sophia, Veeriah Selvaraju, Colliver Emma, Huebner Ariana, Bunkum Abigail, Hill Mark S, Grigoriadis Kristiana, Moore David A, Black James R M, Liu Wing Kin, Thol Kerstin, Pich Oriol, Watkins Thomas B K, Naceur-Lombardelli Cristina, Cook Daniel E, Salgado Roberto, Wilson Gareth A, Bailey Chris, Angelova Mihaela, Bentham Robert, Martínez-Ruiz Carlos, Abbosh Christopher, Nicholson Andrew G, Le Quesne John, Biswas Dhruva, Rosenthal Rachel, Puttick Clare, Hessey Sonya, Lee Claudia, Prymas Paulina, Toncheva Antonia, Smith Jon, Xing Wei, Nicod Jerome, Price Gillian, Kerr Keith M, Naidu Babu, Middleton Gary, Blyth Kevin G, Fennell Dean A, Forster Martin D, Lee Siow Ming, Falzon Mary, Hewish Madeleine, Shackcloth Michael J, Lim Eric, Benafif Sarah, Russell Peter, Boleti Ekaterini, Krebs Matthew G, Lester Jason F, Papadatos-Pastos Dionysis, Ahmad Tanya, Thakrar Ricky M, Lawrence David, Navani Neal, Janes Sam M, Dive Caroline, Blackhall Fiona H, Summers Yvonne, Cave Judith, Marafioti Teresa, Herrero Javier, Quezada Sergio A, Peggs Karl S, Schwarz Roland F, Van Loo Peter, Miedema Daniël M, Birkbak Nicolai J, Hiley Crispin T, Hackshaw Allan, Zaccaria Simone, , Jamal-Hanjani Mariam, McGranahan Nicholas, Swanton Charl |
Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study. Frontiers in oncology 2023 3 13 1113696. Gow Chien-Hung, Hsieh Min-Shu, Chen Yi-Lin, Liu Yi-Nan, Wu Shang-Gin, Shih Jin-Yu |
The diagnostic significance of cerebrospinal fluid cytology and circulating tumor DNA in meningeal carcinomatosis. Frontiers in neurology 2023 3 14 1076310. Di Wei-Ying, Chen Ya-Nan, Cai Yun, Geng Qiang, Tan Yan-Li, Li Chun-Hui, Wang Ya-Nan, Shang Yan-Hong, Fang Chuan, Cheng Shu-J |
An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncology. Laboratory investigation; a journal of technical methods and pathology 2023 2 101 (5): 648-660. Piton Nicolas, Lanic Marie-Delphine, Marguet Florent, Lamy Aude, Blanchard France, Guisier Florian, Viennot Mathieu, Salaün Mathieu, Thiberville Luc, Jardin Fabrice, Sabourin Jean-Christophe, Ruminy Philip |
Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer. JAMA network open 2023 12 6 (12): e2347700. Tomohiro Sakamoto, Taichi Matsubara, Takayuki Takahama, Toshihide Yokoyama, Atsushi Nakamura, Takaaki Tokito, Tatsuro Okamoto, Hiroaki Akamatsu, Masahide Oki, Yuki Sato, Kazunori Tobino, Satoshi Ikeda, Masahide Mori, Chihiro Mimura, Ken Maeno, Satoru Miura, Toshiyuki Harada, Kunihiro Nishimura, Manabu Hiraoka, Hirotsugu Kenmotsu, Junya Fujimoto, Mototsugu Shimokawa, Nobuyuki Yamamoto, Kazuhiko Nakaga |
Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective. Pathology, research and practice 2023 12 253 155013. Aditi Aggarwal, Shivani Sharma, Zoya Brar, Vipin Kumar, Akash Kumar, Rahul Katara, Sambit K Mohan |
Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach. Cellular oncology (Dordrecht) 2023 11 . Jingtao Wei, Ke Ji, Yue Zhang, Ji Zhang, Xiaojiang Wu, Xin Ji, Kai Zhou, Xuesong Yang, Hongfeng Lu, Anqiang Wang, Zhaode |
PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
Pulmonary Low Malignant Potential Adenocarcinoma: A Validation of the Proposed Criteria for This Novel Subtype. The American journal of surgical pathology 2023 11 . Alessandra Pittaro, Filippo Crivelli, Giulia Orlando, Francesca Napoli, Vanessa Zambelli, Francesco Guerrera, Simona Sobrero, Marco Volante, Luisella Righi, Mauro Papot |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: